Kairos Ventures invests in ideas, patents, and businesses from the top universities and scientists.
Business Model: B2B
Revenue: $0
Employees: 0-0
Address: 9440 Santa Monica Blvd Ste 710
City: Beverly Hills
State: CA
Zip: 90210
Country: US
Kairos Ventures invests in ideas, patents, and businesses from the top universities and scientists. Kairos Venture Investments works to get science into the hands of applicable companies. Their team possesses an extraordinary passion to have a huge impact on our world through the creation of companies that will improve our lives and that of the generations that will follow. They aim to do this by backing the very best scientists, engineers and entrepreneurs and help them transform their knowledge, ideas and discoveries into viable businesses. They expect these companies to have a huge impact on the world and create significant returns for their shareholders.
Contact Phone:
+13102711866
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2017 | 3D Bio Holdings | Seed Round | - |
1/2019 | Stoicheia | Seed Round | 5M |
1/2018 | Tanvas | Series A | - |
3/2017 | Neuro-Bio | Series A | 3.2M |
9/2015 | Provivi | Series A | 7.5M |
2/2019 | Transient Plasma Systems, Inc. | Series A | 8.5M |
10/2017 | MixComm | Series A | - |
9/2017 | Sienza Energy | Seed Round | - |
11/2017 | Symbiotix Biotherapies | Venture Round | 5M |
11/2017 | Provivi | Series B | 21M |
10/2019 | Provivi | Series C | 0 |
4/2016 | Compellon | Series A | 6.7M |
8/2017 | DEARhealth | Seed Round | - |
4/2021 | TULU | Seed Round | 0 |
9/2017 | Repairogen | Seed Round | 1M |
10/2016 | MemiRay | Series A | - |
11/2019 | GuRu | Series A | 15M |
4/2016 | Applaud Medical | Series A | - |
9/2017 | GuRu | Seed Round | - |
9/2018 | Linnaeus Therapeutics | Series A | 4.4M |
9/2019 | Linnaeus | Series B | 12M |
3/2016 | Delpor | Series A | 1M |
7/2016 | KMLabs | Series A | 7.2M |
5/2019 | Xidas | Series A | 6M |
11/2016 | Axial Biotherapeutics | Series A | 19.5M |
1/2021 | Novosteo | Series A | 0 |
12/2020 | Provivi | Series C | 0 |
12/2016 | Axial Biotherapeutics | Series A | 19.1M |
9/2017 | Opera Therapeutics | Seed Round | - |
5/2020 | FGC Plasma Solutions | Venture Round | - |
1/2020 | Actinia | Venture Round | - |
3/2017 | Amorphology | Seed Round | - |
11/2017 | 1200 Pharma | Seed Round | 6.2M |
6/2018 | PolyCera Membranes | Series A | 0 |
5/2019 | Actuate Therapeutics | Series B | 0 |
11/2019 | Actuate Therapeutics | Series B | 0 |
1/2019 | Siege Pharmaceuticals | Venture Round | - |
1/2020 | PteroDynamics | Venture Round | - |
12/2019 | Pinpoint Therapeutics | Debt Financing | 0 |
1/2019 | NVasc | Venture Round | - |
12/2019 | Behavioral Signals | Series A | 7M |
9/2017 | Transient Plasma Systems (TPS) | Seed Round | - |
5/2017 | Holoclara | Seed Round | - |
6/2020 | Foldax | Series D | 0 |
2/2018 | nFugue | Seed Round | - |
8/2017 | NanoClear Technologies | Seed Round | - |
6/2018 | Lifesprout | Seed Round | 6.5M |
3/2021 | AetherTouch | Seed Round | - |
7/2017 | Actinobac Biomed | Venture Round | 4.4M |
1/2018 | Keren Therapeutics | Venture Round | - |
11/2019 | MixComm | Series B | 8.6M |
8/2017 | Chimera Bioengineering | Seed Round | - |
3/2021 | Vivodyne | Venture Round | 2M |
4/2021 | TULU | Seed Round | 0 |
3/2021 | Vivodyne | Venture Round | 0 |
3/2021 | AetherTouch | Seed Round | - |
1/2021 | Novosteo | Series A | 0 |
12/2020 | Provivi | Series C | 0 |
6/2020 | Foldax | Series D | 0 |
5/2020 | FGC Plasma Solutions | Venture Round | - |
1/2020 | Actinia | Venture Round | - |
1/2020 | PteroDynamics | Venture Round | - |
12/2019 | Pinpoint Therapeutics | Debt Financing | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|